Recombinant human thrombopoietin improves hematopoietic stem cell differentiation and T-cell immune homeostasis in patients with severe aplastic anemia by upregulating c-MPL
BackgroundRecombinant human thrombopoietin (rhTPO) regulates platelet production by promoting megakaryocyte proliferation and has shown promising therapeutic effects in hematopoietic recovery for severe aplastic anemia (SAA). However, its potential impact on immune cells remains unclear.MethodsThis...
Saved in:
| Main Authors: | Ling Deng, Chenchen Liu, Yiyu Guo, Chunyan Liu, Rong Fu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1542837/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multi-omics analysis links NFKB1 activation to poor immunosuppressive therapy response in acquired aplastic anemia
by: Nianbin Li, et al.
Published: (2025-12-01) -
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
by: Alessandro Pecci, et al.
Published: (2017-11-01) -
Efficacy and safety of hematopoietic stem cell transplantation vs. immunosuppressive therapy in patients with hepatitis-associated aplastic anemia: a systematic review and meta-analysis
by: Yaonan Hong, et al.
Published: (2025-12-01) -
Haplo-hematopoietic stem cell transplantation and immunoradiotherapy for severe aplastic anemia complicated with nasopharyngeal carcinoma: A case report
by: Gao Yanting, et al.
Published: (2025-07-01) -
Rapid early remission in a patient with severe aplastic anemia: a case report of hetrombopag, cyclosporine, and danazol combination therapy
by: Yuting Dai, et al.
Published: (2025-08-01)